REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Antigen, Epitope, Or Other Immunospecific Immunoeffector (e.g., Immunospecific Vaccine, Immunospecific Stimulator Of Cell-mediated Immunity, Immunospecific Tolerogen, Immunospecific Immunosuppressor, Etc.) > Bacterium Or Component Thereof Or Substance Produced By Said Bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, Etc.) > Neisseria (e.g., Neisseria Gonorrhoeae, Etc.) > Neisseria Meningitidis Neisseria MeningitidisNeisseria Meningitidis patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.06/28/07 - 20070148190 - Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine The present invention describes derivatized polysaccharide-protein conjugates, a composition comprising one or more of such derivatized polysaccharide-protein conjugates and methods of immunizing human patients with the same. The derivatized polysaccharide-protein conjugates are purified capsular polysaccharides from Nesseria meningitidis serogroups A, C, W-135, and/or Y, derivatized chemically activated and selectively attached ... 06/07/07 - 20070128230 - Protein nmb0928 and use thereof in pharmaceutical formulations In order to achieve this goal the NMB0928 protein was isolated and identified as a component of outer membrane preparations of Neisseria meningitidis capable of inducing bactericidal activity. Additionally the gene codifying for NMB0928 protein was cloned and expressed, and the said polypeptide was purified and its immunogenicity evaluated in ... 05/31/07 - 20070122434 - Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus Methods and compositions comprising isolated nucleic acid molecules specific to Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus heat shock proteins (Hsps), as well as vector constructs and isolated polypeptides specific to the same are provided. Such compositions and methods are useful for the diagnosis of infections by these organisms and ... 05/31/07 - 20070122433 - Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability The present invention provides a method for producing a less-painful immunogenic composition of a hydrophobic protein in a pharmaceutically acceptable carrier suitable for administering to a mammal, comprising the steps of (a) solubilizing said hydrophobic protein with a zwitterionic detergent to make a first composition; (b) altering said first composition, ... 04/19/07 - 20070087018 - Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof Nucleic acid and amino acid sequences of the Omp85 proteins of N. gonorrhoeae and N. meningitidis, and fragments thereof are useful in vaccine compositions, therapeutic compositions and diagnostic compositions for use in the prevention, treatment and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic ... 04/19/07 - 20070087017 - Ultrafiltration for preparing outer membrane vesicles In place of a step of centrifugation during preparation of outer membrane vesicles (OMVs) from bacteria, the invention utilises ultrafiltration. This allows much larger amounts of OMV-containing supernatant to be processed in a much shorter time. Thus the invention provides a process for preparing bacterial OMVs, comprising a step of ... 04/12/07 - 20070082014 - Injectable vaccines against multiple meningococcal serogroups An injectable immunogenic composition comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of Neisseria meningitidis, wherein said capsular saccharides are conjugated to carrier protein(s) and/or are oligosaccharides, and wherein (i) the composition comprises <50 μg meningococcal saccharide per dose, and/or (ii) the composition further ... 03/15/07 - 20070059329 - Unexpected surface proteins in meningococcus 217 proteins have, contrary to expectations, been found in the membrane of Neisseria meningitidis. Of these 217, 76 in particular evaded all algorithmic methods for predicting membrane localisation. Existing knowledge of protein trafficking pathways in meningococcus does not explain how or why these proteins are located in the bacterial membrane ... 02/01/07 - 20070026021 - Neisseria meningitidis antigens and compositions This invention provides, among other things, protein, polypeptides, and fragments thereof, derived from bacteria Neisseria meningitidis B. Also provided are nucleic acids encoding for such proteins, polypeptides, and/or fragments, as well as nucleic acids complementary thereto (e.g., antisense nucleic acids). Additionally, this invention provides antibodies which bind to the proteins, ... 05/25/06 - 20060110412 - Vaccine composition The present invention relates to vaccine compositions for the effective prevention of neisserial, preferably meningococcal, disease. The vaccine of the invention comprise a multivalent meningococcal bled composition comprising at least one bleb with homologous bactericidal activity which is derived from a meningococcal strain with a serosubtype that is prevalent in ... 04/27/06 - 20060088554 - Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine The present invention describes derivatized polysaccharide-protein conjugates, a composition comprising one or more of such derivatized polysaccharide-protein conjugates and methods of immunizing human patients with the same. The derivatized polysaccharide-protein conjugates are purified capsular polysaccharides from Neisseria meningitidis serogroups A, C, W-135, and Y, derivatized chemically activated and selectively attached ... 04/27/06 - 20060088553 - Medicament for the treatment of diseases due to infection by neisseria meningitidis A medicament for the treatment or prevention of diseases due to infection by Neisseria meningitidis, characterized in that it comprises glycoconjugates and/or lipooligosaccharides (LOS) included in outer membrane vesicles, blebs, lipid layers, liposomes and/or killed or commensal bacteria with cross-reactive antigens to Neisseria meningitidis of the serogroup A, B, C, ... 01/12/06 - 20060008476 - Adjuvanted antigenic meningococcal compositions A composition comprising a Neisserial antigen and a detoxified ADP-ribosylating toxin. These compositions have been found to be useful for mucosal immunisation, particularly nasal immunisation against Neisseria meningitidis. ... ### FreshPatents.com Support |